|View printer-friendly version|
ASLAN Pharmaceuticals Announces Participation at Two Upcoming Virtual Investor Conferences
MENLO PARK, Calif. and SINGAPORE, Nov. 22, 2021 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (Nasdaq: ASLN), a clinical-stage, immunology-focused biopharmaceutical company developing innovative treatments to transform the lives of patients, today announced that Dr Carl Firth, CEO, will be participating in fireside chats at two upcoming virtual health conferences. The details are as follows:
Piper Sandler 33rd Annual Virtual Healthcare Conference
4th Annual Evercore ISI HealthCONx Conference
Both discussions will be accessible afterwards within the News & Events section of ASLAN’s Investor Relations website at https://ir.aslanpharma.com/.
Media and IR contacts
About ASLAN Pharmaceuticals